Romanian drug maker LaborMed Pharma sees its turnover rising to 100 million euro ($155 million) this year from a preliminary 28 million euro in 2007 and considers acquisitions in Poland, Russia and Turkey in the next four to five years, the company's new CEO Stephen Stead said on Thursday.